Tag: AstraZeneca lung cancer drug

AstraZeneca lung cancer drug Tagrisso gets FDA breakthrough therapy designation

pharmanewsdaily- October 15, 2017

Pharma news updates : Tagrisso (osimertinib), the AstraZeneca lung cancer drug has bagged the breakthrough therapy designation (BTD) from the US FDA for the treatment ... Read More